Breast Cancer Diagnosis System Research Articles

The application of mammography imaging in the diagnosis and prediction of breast diseases

Breast diseases pose a significant threat to women’s health, so early detection and treatment are extremely important. In this context, early disease identification has become crucial in the diagnosis and treatment of breast diseases. This paper begins by outlining the pivotal role of mammography in the early diagnosis of breast cancer, comparing the structural similarities and differences between normal and diseased breast tissues. This comparison underscores the primary role of mammography in the diagnosis and treatment of breast diseases. Additionally, our paper provides an overview of fundamental concepts related to breast cancer detection, diagnosis, and prediction systems. It delves into the latest research developments in auxiliary diagnostic detection, examination, and risk prediction systems associated with breast cancer. Our objective is to offer a comprehensive understanding of the role of computer-aided detection, diagnosis, and prediction systems in breast diseases, fostering further development and application. This work aims to explore and drive innovation in the field, enhance early detection rates of breast diseases, and guide readers towards novel directions, thus contributing to female healthcare management.

Artificial intelligence auxiliary diagnosis and treatment system for breast cancer in developing countries.

In many developing countries, a significant number of breast cancer patients are unable to receive timely treatment due to a large population base, high patient numbers, and limited medical resources. This paper proposes a breast cancer assisted diagnosis system based on electronic medical records. The goal of this system is to address the limitations of existing systems, which primarily rely on structured electronic records and may miss crucial information stored in unstructured records. The proposed approach is a breast cancer assisted diagnosis system based on electronic medical records. The system utilizes breast cancer enhanced convolutional neural networks with semantic initialization filters (BC-INIT-CNN). It extracts highly relevant tumor markers from unstructured medical records to aid in breast cancer staging diagnosis and effectively utilizes the important information present in unstructured records. The model's performance is assessed using various evaluation metrics. Such as accuracy, ROC curves, and Precision-Recall curves. Comparative analysis demonstrates that the BC-INIT-CNN model outperforms several existing methods in terms of accuracy and computational efficiency. The proposed breast cancer assisted diagnosis system based on BC-INIT-CNN showcases the potential to address the challenges faced by developing countries in providing timely treatment to breast cancer patients. By leveraging unstructured medical records and extracting relevant tumor markers, the system enables accurate staging diagnosis and enhances the utilization of valuable information.

Signal processing and machine learning in healthcare

Machine learning is the field of artificial intelligence and its important branch. With the continuous innovation of technology, its application in the medical field is increasingly extensive and in-depth. In view of the current human eye discrimination instability and lack of experience, this paper proposes the application of machine learning method, through the training of various attributes of breast cancer data, so that the breast cancer diagnosis system can automatically diagnose malignant breast cancer patients, reduce the influence of human operation on the existence time and experience.

An integrated system for breast cancer diagnosis using convolution neural network and attention mechanism

<p>In most malignancies, breast cancer is fatal, accounting for approximately 500,000 annual deaths. The subtype of breast cancer known as Invasive Ductal Carcinoma (IDC) is surprisingly common. Pathologists commonly focus on IDC-containing regions when trying to determine if a patient has breast cancer. Although extremely fatal, survival rates and expected lifespans improve dramatically with prompt diagnosis and treatment. The treatment strategy also varies based on the breast cancer patient’s stage. In this research, we use a classification method for a publically available dataset of breast histopathology images obtained from the Kaggle. The IDC regions of the images in this dataset have been restricted for easy retrieval. The breast cancer IDC data set contains 277,524 records, of which 78,786 are positive. The 277,524 images were classified using an IDC breast cancer dataset, with 78,786 positive IDC and 198,738 negative IDC, respectively. The authors introduce a new architecture of deep convolutional neural networks and attention mechanism for classification. The model achieves state-of-the-art levels of accuracy for IDC identification, setting a new benchmark for future studies.</p>

An Efficient Breast Cancer Segmentation System based on Deep Learning Techniques

Breast cancer is one of the major threats that attack women around the world. Its detection and diagnosis in the early stages can greatly improve care efficiency and reduce mortality rate. Early detection of breast cancer allows medical professionals to use less intrusive treatments, such as lumpectomies or targeted medicines, improving survival rates and lowering morbidity. This study developed a breast cancer segmentation system based on an improved version of the U-Net 3+ neural network. Various optimizations were applied to this architecture to improve the localization and segmentation performance. An evaluation of different state-of-the-art networks was performed to improve the performance of the proposed breast cancer diagnosis system. Various experiments were carried out on the INbreast Full-Field Digital Mammographic dataset (INbreast FFDM). The results obtained demonstrated that the proposed model achieved a dice score of 98.47%, which is a new state-of-the-art segmentation finding, showcasing its efficiency in detecting breast cancer from mammography images with the possibility of implementation for real applications.

Hybrid Intelligent Pattern Recognition Systems for Mass Segmentation and Classification: A Pilot Study on Full-Field Digital Mammograms

Governments and health authorities emphasize the importance of early detection of breast cancer, usually through mammography, to improve prognosis, increase therapeutic options and achieve optimum outcomes. Despite technological advances and the advent of full-field digital mammography (FFDM), diagnosis of breast abnormalities on mammographic images remains a challenge due to qualitative variations in different tissue types and densities. Highly accurate computer-aided diagnosis (CADx) systems could assist in the differentiation between normal and abnormal tissue and the classification of abnormal tissue as benign or malignant. In this paper, classical, advanced fuzzy sets and fusion techniques for image enhancement were combined with three different thresholding methods (Global, Otsu and type-2 fuzzy sets threshold) and three different classifying techniques (K-means, FCM and ANFIS) for the classification of breast masses on FFDM. The aim of this paper is to identify the performance of the advanced fuzzy sets, fuzzy sets type-2 segmentation, decisions based on K-means and FCM, and the ANFIS classifier. Sixty-three combinations were evaluated on ninety-seven digital mammographic masses (sixty-five benign and thirty-two malignant). The performance of the sixty-three combinations was evaluated by estimating the accuracy, the F1 score, and the area under the curve (AUC). LH-XWW enhancement method with Otsu thresholding and FCM classifier outperformed all other combinations with an accuracy of 95.17%, F1 score of 89.42% and AUC of 0.91. This algorithm seems to offer a promising CADx system for breast cancer diagnosis on FFDM.

Optimized Bayesian convolutional neural networks for invasive breast cancer diagnosis system

Deep learning (DL) has depicted unprecedented results in the diagnosis of invasive ductal carcinoma (IDC). However, most DL methods are not able to infer the uncertainty in their predictions, and are often too confident which may cause undesirable consequences. The ability of DL models to express their uncertainty in their predictions is particularly important in diagnosing diseases. Therefore, this paper proposes an uncertainty-aware approach called optimized Bayesian convolutional neural network (OBCNN) for the automated detection of IDC from histopathology images and is capable of estimating and inferring the uncertainty in its predictions. The proposed OBCNN employs an approximate Bayesian version of a pre-trained convolutional neural network (CNN) model named ResNet101V2 that is fine-tuned to the histopathology images of IDC. The Bayesian approximation is performed by adding Monte Carlo dropout (MC-dropout) to ResNet101V2 architecture. Due to the effect of MC-dropout on the obtained posterior predictive distribution (PPD), the value of MC-dropout should be chosen carefully because if the MC-dropout value is too large, the predictive distribution (PD) will be very diverse. Whereas if the MC-dropout value is very small, the PD will be very similar. Therefore, an optimization algorithm known as the slime mould algorithm is utilized to set the optimal value of the MC-dropout. During inference, the proposed OBCNN runs for T forward passes to configure the PPD. The mean, standard deviation (SD) and entropy are then calculated over the obtained PD to estimate the predictive uncertainty (PU) of the OBCNN. The proposed OBCNN achieved an accuracy of 93.83%, a precision of 96.14%, a G-mean of 93.04%, False Negative Rate of 4.72%, and False Positive Rate of 9.96 %. The proposed OBCNN has also been compared with recent related work, the comparison’s results demonstrated that OBCNN performed better in the diagnosis of IDC.

A robust and efficient AI assistant for breast tumor segmentation from DCE-MRI via a spatial-temporal framework

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) allows screening, follow up, and diagnosis for breast tumor with high sensitivity. Accurate tumor segmentation from DCE-MRI can provide crucial information of tumor location and shape, which significantly influences the downstream clinical decisions. In this paper, we aim to develop an artificial intelligence (AI) assistant to automatically segment breast tumors by capturing dynamic changes in multi-phase DCE-MRI with a spatial-temporal framework. The main advantages of our AI assistant include (1) robustness, i.e., our model can handle MR data with different phase numbers and imaging intervals, as demonstrated on a large-scale dataset from seven medical centers, and (2) efficiency, i.e., our AI assistant significantly reduces the time required for manual annotation by a factor of 20, while maintaining accuracy comparable to that of physicians. More importantly, as the fundamental step to build an AI-assisted breast cancer diagnosis system, our AI assistant will promote the application of AI in more clinical diagnostic practices regarding breast cancer.

A two-stage feature selection approach using hybrid quasi-opposition self-adaptive coati optimization algorithm for breast cancer classification

Breast cancer (BC) is one of the leading causes of high mortality rates among women. An early disease diagnosis is crucial in breast cancer’s treatment for improving the survival rate of people who have been afflicted. Human error, incorrect diagnoses, and insufficient time make manual techniques for breast cancer diagnosis ineffective and inefficient. An automated breast cancer diagnosis system assists the medical expert in diagnosing the cancer at its earliest stage. When attempting to investigate all aspects (high dimensionality) of the medical records, the automated diagnosis system faces significant challenges. It reduces the success rate of the diagnosis system. This study presents a two-stage feature subset selection approach using quasi-opposition self-adaptive coati optimization algorithm for breast cancer classification. The proposed scheme’s fitness function aims to maximize the success rate and minimize the feature selection ratio. We used the three benchmark datasets (Breast Cancer Wisconsin Diagnostic Dataset (WDBC), Breast Cancer Wisconsin Prognostic Dataset (WPBC), and Breast Cancer Wisconsin Original Dataset (WBCD)) to examine the proposed scheme’s performance. The comparison analysis results show that the proposed scheme outperforms the other competitor schemes.

An ensemble classifier method based on teaching-learning-based optimization for breast cancer diagnosis.

Epidemiological studies show that breast cancer is the most common cancer in women in the world. Breast cancer treatment can be very effective, especially when the disease is detected in the early stages. The goal can be achieved by using large-scale breast cancer data with the machine learning models METHODS: This paper proposes a new intelligent approach using an optimized ensemble classifier for breast cancer diagnosis. The classification is done by proposing a new intelligent Group Method of Data Handling (GMDH) neural network-based ensemble classifier. This method improves the performance of the machine learning technique by using a Teaching-Learning-Based Optimization (TLBO) algorithm to optimize the hyperparameters of the classifier. Meanwhile, we use TLBO as an evolutionary method to address the problem of appropriate feature selection in breast cancer data. The simulation results show that the proposed method has a better accuracy between 7 and 26% compared to the best results of the existing equivalent algorithms. According to the obtained results, we suggest the proposed algorithm as an intelligent medical assistant system for breast cancer diagnosis.

Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification.

Feature selection in the face of high-dimensional data can reduce overfitting and learning time, and at the same time improve the accuracy and efficiency of the system. Since there are many irrelevant and redundant features in breast cancer diagnosis, removing such features leads to more accurate prediction and reduced decision time when dealing with large-scale data. Meanwhile, ensemble classifiers are powerful techniques to improve the prediction performance of classification models, where several individual classifier models are combined to achieve higher accuracy. In this paper, an ensemble classifier algorithm based on multilayer perceptron neural network is proposed for the classification task, in which the parameters (e.g., number of hidden layers, number of neurons in each hidden layer, and weights of links) are adjusted based on an evolutionary approach. Meanwhile, this paper uses a hybrid dimensionality reduction technique based on principal component analysis and information gain to address this problem. The effectiveness of the proposed algorithm was evaluated based on the Wisconsin breast cancer database. In particular, the proposed algorithm provides an average of 17% better accuracy compared to the best results obtained from the existing state-of-the-art methods. Experimental results show that the proposed algorithm can be used as an intelligent medical assistant system for breast cancer diagnosis.

Deep learning for real-time detection of breast cancer presenting pathological nipple discharge by ductoscopy.

As a common breast cancer-related complaint, pathological nipple discharge (PND) detected by ductoscopy is often missed diagnosed. Deep learning techniques have enabled great advances in clinical imaging but are rarely applied in breast cancer with PND. This study aimed to design and validate an Intelligent Ductoscopy for Breast Cancer Diagnostic System (IDBCS) for breast cancer diagnosis by analyzing real-time imaging data acquired by ductoscopy. The present multicenter, case-control trial was carried out in 6 hospitals in China. Images for consecutive patients, aged ≥18 years, with no previous ductoscopy, were obtained from the involved hospitals. All individuals with PND confirmed from breast lesions by ductoscopy were eligible. Images from Beijing Chao-Yang Hospital were randomly assigned (8:2) to the training (IDBCS development) and internal validation (performance evaluation of the IDBCS) datasets. Diagnostic performance was further assessed with internal and prospective validation datasets from Beijing Chao-Yang Hospital; further external validation was carried out with datasets from 5 primary care hospitals. Diagnostic accuracies, sensitivities, specificities, and positive and negative predictive values for IDBCS and endoscopists (expert, competent, or trainee) in the detection of malignant lesions were obtained by the Clopper-Pearson method. Totally 11305 ductoscopy images in 1072 patients were utilized for developing and testing the IDBCS. Area under the curves (AUCs) in breast cancer detection were 0·975 (95%CI 0·899-0·998) and 0·954 (95%CI 0·925-0·975) in the internal validation and prospective datasets, respectively, and ranged between 0·922 (95%CI 0·866-0·960) and 0·965 (95%CI 0·892-0·994) in the 5 external validation datasets. The IDBCS had superior diagnostic accuracy compared with expert (0.912 [95%CI 0.839-0.959] vs 0.726 [0.672-0.775]; p<0.001), competent (0.699 [95%CI 0.645-0.750], p<0.001), and trainee (0.703 [95%CI 0.648-0.753], p<0.001) endoscopists. IDBCS outperforms clinical oncologists, achieving high accuracy in diagnosing breast cancer with PND. The novel system could help endoscopists improve their diagnostic efficacy in breast cancer diagnosis.

An efficient hybrid computer-aided breast cancer diagnosis system with wavelet packet transform and synthetically-generated contrast-enhanced spectral mammography images

Contrast-enhanced spectral mammography (CESM) is an emerging modality for breast cancer diagnosis. This work investigates the feasibility of a computationally-efficient computer-aided diagnosis (CAD) system for breast lesion classification. Moreover, to avoid the need for intravenous contrast agents, we investigated the synthesis of contrast-enhanced (SynCESM) images. A total of 504 pairs of low-energy (LE) and CESM images were collected from 160 female subjects. A semi-automatic active-contour method was used for lesion segmentation. Then, 20 morphological and textural features were extracted. To improve the computational efficiency of the proposed system, the wavelet packet transform (WPT) was applied. Then, the same features were extracted from the WPT-approximated segmented lesions. Using LE images, a sigmoid-kernel SVM classifier exhibited a 90.20% accuracy, an 88.39% sensitivity, an 88.26% specificity, and a 0.92 AUC. The per-frame classification time was significantly reduced from 1.1046 s to 0.0734 s with WPT. Using CESM images, we achieved a 93.26% accuracy, a 95.94% sensitivity, a 93.37% specificity, a 0.94 AUC, and a 0.0657 s classification time. Interestingly, with SynCESM images, reasonable performance was still obtained with a 92.14% accuracy, a 93.87% sensitivity, a 91.58% specificity, a 0.93 AUC and a 0.0657 s classification time. Finally, with hybrid pairs of LE and CESM images, we got the best performance with a 96.87% accuracy, a 97.23% sensitivity, a 95.47% specificity, a 0.98 AUC, and a 0.0696 s classification time. The results demonstrate several advantages of the proposed system including its clinical feasibility, lower complexity, and reduced need for contrast agents via synthetic data generation.

A novel multistage CAD system for breast cancer diagnosis

A novel multistage CAD system for breast cancer diagnosis

SELF: a stacked-based ensemble learning framework for breast cancer classification

Nowadays, breast cancer is the most prevalent and jeopardous disease in women after lung cancer. During the past few decades, a substantial amount of cancer cases have been reported throughout the world. Breast cancer has been a widely acknowledged category of cancer disease in women due to the lack of awareness. According to the world cancer survey report 2020, about 2.3 million cases and 685,000 deaths have been reported worldwide. As, the patient-doctor ratio (PDR) is very high; consequently, there is an utmost need for a machine-based intelligent breast cancer diagnosis system that can detect cancer at its early stage and cure it more efficiently. The plan is to assemble scientists in both the restorative and the machine learning fields to progress toward this clinical application. This paper presents SELF, a stacked-based ensemble learning framework, to classify breast cancer at an early stage from the histopathological images of tumor cells with computer-aided diagnosis tools. In this work, we use the BreakHis dataset with 7909 histopathological images and Wisconsin Breast Cancer Database (WBCD) with 569 instances for the performance evaluation of our proposed framework. We have trained several distinct classifiers on both datasets and selected the best five classifiers on the basis of their accuracy measure to create our ensemble model. We use the stacking ensemble technique and consider the Extra tree, Random Forest, AdaBoost, Gradient Boosting, and KNN9 classifiers as the base learners, and the logistic regression model as a final estimator. We have evaluated the performance of SELF on the BreakHis dataset and WBCD datasets and achieved testing accuracy of approximately 95% and 99% respectively. The result of the other performance parameters on the BreakHis and the WBCD datasets also showed that our proposed framework outperforms with F1-Score, ROC, and MCC scores.

Designing a Deep Learning-Driven Resource-Efficient Diagnostic System for Metastatic Breast Cancer: Reducing Long Delays of Clinical Diagnosis and Improving Patient Survival in Developing Countries.

Breast cancer is one of the leading causes of cancer mortality. Breast cancer patients in developing countries, especially sub-Saharan Africa, South Asia, and South America, suffer from the highest mortality rate in the world. One crucial factor contributing to the global disparity in mortality rate is long delay of diagnosis due to a severe shortage of trained pathologists, which consequently has led to a large proportion of late-stage presentation at diagnosis. To tackle this critical healthcare disparity, we have developed a deep learning-based diagnosis system for metastatic breast cancer that can achieve high diagnostic accuracy as well as computational efficiency and mobile readiness suitable for an under-resourced environment. We evaluated 4 Convolutional Neural Network (CNN) architectures: MobileNetV2, VGG16, ResNet50 and ResNet101. The MobileNetV2-based diagnostic model outperformed the more complex VGG16, ResNet50 and ResNet101 models in diagnostic accuracy, model generalization, and model training efficiency. The ROC AUC of MobilenetV2 (0.933, 95% CI: 0.930, 0.936) was higher than VGG16 (0.911, 95% CI: 0.908, 0.915), ResNet50 (0.869, 95% CI: 0.866, 0.873), and ResNet101 (0.873, 95% CI: 0.869, 0.876). The time per inference step for the MobileNetV2 model (15 ms/step) was substantially lower than that of VGG16 (48 ms/step), ResNet50 (37 ms/step), and ResNet110 (56 ms/step). The visual comparisons between the model prediction and ground truth have demonstrated that the MobileNetV2 diagnostic models can identify very small cancerous nodes embedded in a large area of normal cells which is challenging for manual image analysis. Equally Important, the light weight MobleNetV2 models were computationally efficient and ready for mobile devices or devices of low computational power. These advances empower the development of a resource-efficient and high performing AI-based metastatic breast cancer diagnostic system that can adapt to under-resourced healthcare facilities in developing countries.

A Multimodal, Usable, and Flexible Clinical Decision-Support System for Breast Cancer Diagnosis and Reporting

A Multimodal, Usable, and Flexible Clinical Decision-Support System for Breast Cancer Diagnosis and Reporting

Classification of Breast Cancer Diagnosis Systems Using Artificial Intelligence Techniques: Survey

Classification of Breast Cancer Diagnosis Systems Using Artificial Intelligence Techniques: Survey

Retraction Note to: Multilevel Tetrolet transform based breast cancer classifier and diagnosis system for healthcare applications

Retraction Note to: Multilevel Tetrolet transform based breast cancer classifier and diagnosis system for healthcare applications

Blockchain integrated multi-agent system for breast cancer diagnosis

&lt;span&gt;The integration of multi-agent system and blockchain technology can be beneficial to healthcare applications by providing intelligent data analysis with security. This paper presents an architecture that integrates multi-agent learning system and blockchain technology to support breast cancer diagnosis in a secured manner. The proposed system is based on a parallel hybrid fuzzy logic approach for supporting the prediction of breast cancer disease. The proposed system showed a classification accuracy of 96.49% in breast cancer diagnosis when testing with the Wisconsin Diagnostic Breast Cancer dataset. The blockchain is used to provide agent security in the proposed system to ensure that the only trusted and reputed agents are participated in the decision-making process.&lt;/span&gt;